- Home
- AVR vs MQT Comparison
AVR vs MQT Comparison
Compare AVR & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- MQT
- Stock Information
- Founded
- AVR 1999
- MQT 1992
- Country
- AVR Australia
- MQT United States
- Employees
- AVR N/A
- MQT N/A
- Industry
- AVR
- MQT Investment Bankers/Brokers/Service
- Sector
- AVR
- MQT Finance
- Exchange
- AVR NYSE
- MQT Nasdaq
- Market Cap
- AVR 215.6M
- MQT 225.5M
- IPO Year
- AVR 2024
- MQT N/A
- Fundamental
- Price
- AVR $8.25
- MQT $10.36
- Analyst Decision
- AVR Strong Buy
- MQT
- Analyst Count
- AVR 4
- MQT 0
- Target Price
- AVR $16.50
- MQT N/A
- AVG Volume (30 Days)
- AVR 109.9K
- MQT 52.5K
- Earning Date
- AVR 01-01-0001
- MQT 01-01-0001
- Dividend Yield
- AVR N/A
- MQT 4.60%
- EPS Growth
- AVR N/A
- MQT N/A
- EPS
- AVR N/A
- MQT N/A
- Revenue
- AVR $2,826,588.00
- MQT N/A
- Revenue This Year
- AVR N/A
- MQT N/A
- Revenue Next Year
- AVR $25.66
- MQT N/A
- P/E Ratio
- AVR N/A
- MQT N/A
- Revenue Growth
- AVR N/A
- MQT N/A
- 52 Week Low
- AVR $5.10
- MQT $8.59
- 52 Week High
- AVR $8.79
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- MQT 62.51
- Support Level
- AVR N/A
- MQT $10.09
- Resistance Level
- AVR N/A
- MQT $10.39
- Average True Range (ATR)
- AVR 0.00
- MQT 0.08
- MACD
- AVR 0.00
- MQT 0.01
- Stochastic Oscillator
- AVR 0.00
- MQT 91.18
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.